| |
Latest 10 SEC filings (by transaction date) for MBIO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 19/23 | Dec 19/23 | Carney Peter | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jul 7/23 | Jul 5/23 | Zelefsky Michael J | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Jul 5/23 | Chill Adam J. | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Jul 5/23 | Rosenwald Lindsay A Md | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Jul 5/23 | Weiss Michael S | Indirect Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Jul 5/23 | Herskowitz Neil | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Apr 24/23 | Litchman Manuel MD | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 5,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for MBIO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 19/23 | Dec 19/23 | Carney Peter | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jul 7/23 | Jul 5/23 | Zelefsky Michael J | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Jul 5/23 | Chill Adam J. | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Jul 5/23 | Rosenwald Lindsay A Md | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Jul 5/23 | Weiss Michael S | Indirect Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Jul 5/23 | Herskowitz Neil | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 7,246 | |
Jul 7/23 | Apr 24/23 | Litchman Manuel MD | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 5,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |